Skip to main content
OpenTrials
Completed

NCT Number: NCT00651690

Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment

This study evaluates the responsiveness of 7 functional tasks to botulinum toxin Type A treatment in poststroke patients with spasticity of the upper-limb flexors

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medically stable poststroke with focal unilateral upper-limb spasticity

Exclusion criteria

  • Stroke within 6 months of the study enrollment visit
  • Previous or current botulinum toxin therapy of any type in the study limb

Treatment and study plan

Botulinum toxin type A

Biological

200 U to 360 U of botulinum toxin Type A on Day 0. Patients who met retreatment criteria received a second treatment (open-label) at Week 12 or Week 18

Other names: BOTOX®

Placebo

Biological

Saline injection on Day 0

Primary outcomes

  1. Seven functional tasks (nail filing, hand cleaning, holding a water bottle, brushing teeth, holding a small fruit, holding a medium fruit, and holding a large fruit)

    Time frame: Week 6

Secondary outcomes

  1. Spasticity of the upper-limb flexors as measured by the Ashworth Scale

    Time frame: Week 6

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Apr 3, 2008
Registry last updated
May 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.